SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

Por Lee, Dustin M., Battson, Micah L., Jarrell, Dillon K., Hou, Shuofei, Ecton, Kayl E., Weir, Tiffany L., Gentile, Christopher L.
Publicado no Cardiovasc Diabetol (2018)

Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction

Por Battson, Micah L., Lee, Dustin M., Jarrell, Dillon K., Hou, Shuofei, Ecton, Kayl E., Weir, Tiffany L., Gentile, Christopher L.
Publicado no Am J Physiol Endocrinol Metab (2018)

Gut microbiota regulates cardiac ischemic tolerance and aortic stiffness in obesity

Por Battson, Micah L., Lee, Dustin M., Li Puma, Lance C., Ecton, Kayl E., Thomas, Keely N., Febvre, Hallie P., Chicco, Adam J., Weir, Tiffany L., Gentile, Christopher L.
Publicado no Am J Physiol Heart Circ Physiol (2019)